Wednesday November 25 2009 | Biotechnology feed | All feeds
|
|
Applied Genetic Technologies, Corporation,
Download detailed PDF Members: Applied Genetic Technologies Corporation (AGTC) was founded in January, 1999 by five scientific leaders in the use of viral vectors for Gene Therapy. They subsequently secured rights to a portfolio of strategically vital intellectual property in the application of Adeno-Associated Virus (AAV) to gene therapy. Since that time the Company has grown to 15 employees (including 6 Ph.D.s), signed licenses to over 40 US and foreign patents, completed two rounds of venture financing, has four products in active development, and signed a major collaboration with a top five Biotech company. AGTC’s most recent round of financing was completed in November 2003 and was led by Interwest Partners of Menlo Park, CA ( www.interwest.com). Other investors included Skyline Ventures of Palo Alto, CA ( www.skylineventures.com); Intersouth Partners of RTP, NC ( www.intersouth.com); and MedImmune Ventures of Gaithersburg, MD ( www.medimmune.com). The Company raised over $20M in this round to fund clinical development of its lead product and to complete scale-up of its manufacturing process.
This page has been viewed 487 times since April 2007, the link to the organisation's website has been followed 76 times Recent Search Terms used to find this page: applied genetic technologies | Applied Genetic Technologies Corp | Advanced Genetic Technologies Corp. Gaithersburg MD | genetic companies in Florida | vital technologies | vital technologies | applied gen | applied genetic technologies | Vital Technologies Corporation | applied genetic | . Search for more companies in Alachua Search for more companies in Florida This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Applied Genetic Technologies, Corporation, | ||||||||||||||||||||||||||
|